Arnold Bolomsky
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
Papers in
- Hematology 23
- Multiple Myeloma Research and Treatments 23
-
- Protein Degradation and Inhibitors 11
- Ubiquitin and proteasome pathways 7
- FOXO transcription factor regulation 2
- Co-authors
- Heinz Ludwig (27 shared papers)Niklas Zojer (21 shared papers)Martin Schreder (12 shared papers)Jo Caers (9 shared papers)Daniel Heintel (6 shared papers)Caroline A. Heckman (3 shared papers)Ulrich Jäger (3 shared papers)Meike Vogler (2 shared papers)
- Journals
- Blood (9 papers)Journal of Hematology & Oncology (4 papers)British Journal of Haematology (3 papers)Haematologica (2 papers)Experimental Hematology (1 paper)
- Partner nations
- AustriaBelgiumUnited States
In The Last Decade
Arnold Bolomsky
28 papers receiving 613 citations
Peers
Comparison fields: 5 of 68
- Hematology 308
- Oncology 185
- Molecular Biology 427
- Pathology and Forensic Medicine 62
- Cancer Research 51
Countries citing papers authored by Arnold Bolomsky
This map shows the geographic impact of Arnold Bolomsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Bolomsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Bolomsky more than expected).
Fields of papers citing papers by Arnold Bolomsky
This network shows the impact of papers produced by Arnold Bolomsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Bolomsky. The network helps show where Arnold Bolomsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnold Bolomsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 140 | |
| 2 | 2020 | 118 | |
| 3 | 2013 | 93 | |
| 4 | 2016 | 45 | |
| 5 | 2014 | 28 | |
| 6 | 2015 | 27 | |
| 7 | 2017 | 25 | |
| 8 | 2016 | 18 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 2020 | 13 | |
| 12 | 2021 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2017 | 11 | |
| 15 | 2012 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2011 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2018 | 3 | |
| 20 | 2017 | 2 |
About Arnold Bolomsky
Arnold Bolomsky is a scholar working on Hematology, Molecular Biology, Pathology and Forensic Medicine, Oncology and Computational Theory and Mathematics, having authored 31 papers that have together received 622 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (11 papers), Ubiquitin and proteasome pathways (7 papers), Cancer Mechanisms and Therapy (6 papers), Peptidase Inhibition and Analysis (3 papers), Chemokine receptors and signaling (3 papers), Computational Drug Discovery Methods (3 papers) and FOXO transcription factor regulation (2 papers). The work is most often cited by research in Hematology (308 citations), Oncology (185 citations), Molecular Biology (427 citations), Pathology and Forensic Medicine (62 citations) and Cancer Research (51 citations). Arnold Bolomsky has collaborated with scholars based in Austria, Belgium and United States. Frequent co-authors include Heinz Ludwig, Niklas Zojer, Martin Schreder, Jo Caers, Daniel Heintel, Caroline A. Heckman, Ulrich Jäger, Meike Vogler, Grégory Ehx and Heinz Gisslinger. Their work appears in journals such as Blood, Journal of Hematology & Oncology, British Journal of Haematology, Haematologica and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.